Stock market today: S&P 500, Dow, Nasdaq slip with fresh tariffs, Fed minutes in focus
Investors are weighing Trump's latest tariff salvo and waiting for Fed minutes for insight into future policy.
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.
Hims & Hers Buys Lab to Expand Into At-Home Blood Testing
Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the ...
Investing54m
Hims & Hers Health stock soars on Trybe Labs acquisition
The acquisition of Trybe Labs, marketed as Sigmund NJ LLC, will enable Hims & Hers to offer comprehensive whole body testing, including at-home blood draws. This addition to the company’s services is ...
infectiousdiseaseadvisor.com55m
Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without ...